These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8784514)

  • 21. The detection of African horse sickness virus antigens and antibodies in young Equidae.
    Hamblin C; Anderson EC; Mellor PS; Graham SD; Mertens PP; Burroughs JN
    Epidemiol Infect; 1992 Feb; 108(1):193-201. PubMed ID: 1547837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of a new lateral flow assay for simultaneous detection of antibodies against African Horse Sickness and Equine Infectious Anemia viruses.
    Costa S; Sastre P; Pérez T; Tapia I; Barrandeguy M; Sánchez-Vizcaíno JM; Sánchez-Matamoros A; Wigdorovitz A; Sanz A; Rueda P
    J Virol Methods; 2016 Nov; 237():127-131. PubMed ID: 27616197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of probes for typing African horsesickness virus isolates using a complete set of cloned VP2-genes.
    Koekemoer JJ; Potgieter AC; Paweska JT; Van Dijk AA
    J Virol Methods; 2000 Aug; 88(2):135-44. PubMed ID: 10960701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group-reactive ELISAs for detecting antibodies to African horsesickness and equine encephalosis viruses in horse, donkey, and zebra sera.
    Williams R; Du Plessis DH; Van Wyngaardt W
    J Vet Diagn Invest; 1993 Jan; 5(1):3-7. PubMed ID: 8385502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of ELISA for the detection of African horse sickness virus antigens and antibodies.
    Rubio C; Cubillo MA; Hooghuis H; Sanchez-Vizcaino JM; Diaz-Laviada M; Plateau E; Zientara S; Crucière C; Hamblin C
    Arch Virol Suppl; 1998; 14():311-5. PubMed ID: 9785516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preparation and identification of monoclonal antibodies against African horse sickness virus VP7].
    DU F; Feng C; Wang C; Qiu S; Zhang Y; Lin X; Wu S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Dec; 34(12):1125-1129. PubMed ID: 30626480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
    van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
    Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, virological and immune responses of normal and immunosuppressed donkeys (Equus asinus africanus) after inoculation with African horse sickness virus.
    Fassi-Fihri O; el Harrak M; Fassi-Fehri MM
    Arch Virol Suppl; 1998; 14():49-56. PubMed ID: 9785495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness.
    Durán-Ferrer M; Agüero M; Zientara S; Beck C; Lecollinet S; Sailleau C; Smith S; Potgieter C; Rueda P; Sastre P; Monaco F; Villalba R; Tena-Tomás C; Batten C; Frost L; Flannery J; Gubbins S; Lubisi BA; Sánchez-Vizcaíno JM; Emery M; Sturgill T; Ostlund E; Castillo-Olivares J
    Transbound Emerg Dis; 2019 Jan; 66(1):83-90. PubMed ID: 30070433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baculovirus expression of non-structural protein NS2 and core protein VP7 of African horsesickness virus serotype 3 and their use as antigens in an indirect ELISA.
    Bremer CW; du Plessis DH; van Dijk AA
    J Virol Methods; 1994 Jul; 48(2-3):245-56. PubMed ID: 7989441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory confirmation of African horsesickness in the western Cape: application of a F(ab')2-based indirect ELISA.
    Du Plessis DH; Van Wyngaardt W; Gerdes GH; Opperman E
    Onderstepoort J Vet Res; 1991 Mar; 58(1):1-3. PubMed ID: 2052314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plant expression systems as an economical alternative for the production of iELISA coating antigen AHSV VP7.
    Fearon SH; Dennis SJ; Hitzeroth II; Rybicki EP; Meyers AE
    N Biotechnol; 2022 May; 68():48-56. PubMed ID: 35114407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VP7 from African horse sickness virus serotype 9 protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara RS; Burroughs JN; Mertens PP
    Arch Virol Suppl; 1998; 14():211-9. PubMed ID: 9785508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Western immunoblotting as a method for the detection of African horse sickness virus protein-specific antibodies: differentiation between infected and vaccinated horses.
    Bougrine SI; Fihri OF; Fehri MM
    Arch Virol Suppl; 1998; 14():329-36. PubMed ID: 9785518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insight into African horsesickness virus infection.
    Manole V; Laurinmäki P; Van Wyngaardt W; Potgieter CA; Wright IM; Venter GJ; van Dijk AA; Sewell BT; Butcher SJ
    J Virol; 2012 Aug; 86(15):7858-66. PubMed ID: 22593166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of African horsesickness.
    Laegreid WW
    Comp Immunol Microbiol Infect Dis; 1994; 17(3-4):297-303. PubMed ID: 8001351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.